BRPI0917862A2 - composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas - Google Patents

composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas

Info

Publication number
BRPI0917862A2
BRPI0917862A2 BRPI0917862A BRPI0917862A BRPI0917862A2 BR PI0917862 A2 BRPI0917862 A2 BR PI0917862A2 BR PI0917862 A BRPI0917862 A BR PI0917862A BR PI0917862 A BRPI0917862 A BR PI0917862A BR PI0917862 A2 BRPI0917862 A2 BR PI0917862A2
Authority
BR
Brazil
Prior art keywords
methods
compositions
prolonged distribution
transdermal donepezil
transdermal
Prior art date
Application number
BRPI0917862A
Other languages
English (en)
Portuguese (pt)
Inventor
Jianye Wen
Yoshiko Katori
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of BRPI0917862A2 publication Critical patent/BRPI0917862A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0917862A 2008-09-30 2009-08-31 composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas BRPI0917862A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10141208P 2008-09-30 2008-09-30
PCT/US2009/055542 WO2010039381A1 (en) 2008-09-30 2009-08-31 Transdermal extended-delivery donepezil compositions and methods for using the same

Publications (1)

Publication Number Publication Date
BRPI0917862A2 true BRPI0917862A2 (pt) 2015-11-24

Family

ID=42057739

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917862A BRPI0917862A2 (pt) 2008-09-30 2009-08-31 composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas

Country Status (12)

Country Link
US (1) US20100080842A1 (enExample)
EP (1) EP2328582A4 (enExample)
JP (1) JP2012504163A (enExample)
CN (1) CN102164601A (enExample)
AR (1) AR073696A1 (enExample)
AU (1) AU2009300184A1 (enExample)
BR (1) BRPI0917862A2 (enExample)
CA (1) CA2733265A1 (enExample)
IL (1) IL210970A0 (enExample)
MX (1) MX2011002260A (enExample)
TW (1) TW201029653A (enExample)
WO (1) WO2010039381A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ605352A (en) 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
JP5850371B2 (ja) * 2010-09-30 2016-02-03 積水メディカル株式会社 貼付剤
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
WO2013078608A1 (en) 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
KR101485822B1 (ko) 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
ES2829807T3 (es) 2014-02-20 2021-06-02 Nal Pharmaceutical Group Ltd Sistema de administración transdérmica de fármacos que contiene donepezilo
JP6793648B2 (ja) * 2014-12-18 2020-12-02 アイキュア ファーマスーティカル インク． ドネペジルを有効成分として含有する経皮吸収製剤
KR102033686B1 (ko) 2017-05-19 2019-10-18 보령제약 주식회사 도네페질을 함유하는 마이크로니들 경피 패치
US20190175520A1 (en) * 2017-12-13 2019-06-13 Corium International, Inc. Method for depot creation during transdermal drug delivery
KR102024996B1 (ko) 2017-12-27 2019-09-25 동아에스티 주식회사 도네페질을 함유하는 치매 치료용 경피흡수제제
KR102372630B1 (ko) 2019-05-15 2022-03-14 주식회사 대웅제약 고함량의 도네페질 또는 그의 염을 포함하는 경피흡수제제
CN112823793A (zh) * 2019-11-20 2021-05-21 成都康弘药业集团股份有限公司 一种含有多奈哌齐的透皮贴剂及其制备方法
WO2024127805A1 (ja) * 2022-12-16 2024-06-20 帝國製薬株式会社 ドネペジル含有経皮吸収製剤

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880633A (en) * 1986-03-12 1989-11-14 Merck & Co., Inc. Transdermal drug delivery system
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5681579A (en) * 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
DE4341444C2 (de) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5759560A (en) * 1995-07-27 1998-06-02 Bio Med Sciences, Inc. Silicone thermoplastic sheeting for scar treatment and useful article thereof; process of manufacture and use
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
TW513409B (en) * 1996-06-07 2002-12-11 Eisai Co Ltd Polymorphs of donepezil hydrochloride
US5716621A (en) * 1996-07-03 1998-02-10 Pharmadyn, Inc. Nonocclusive drug delivery device and process for its manufacture
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
ATE229817T1 (de) * 1996-10-24 2003-01-15 Alza Corp Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US6193993B1 (en) * 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
DE19830649C2 (de) * 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
US6611706B2 (en) * 1998-11-09 2003-08-26 Transpharma Ltd. Monopolar and bipolar current application for transdermal drug delivery and analyte extraction
US6148232A (en) * 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
US6597946B2 (en) * 1998-11-09 2003-07-22 Transpharma Ltd. Electronic card for transdermal drug delivery and analyte extraction
KR100885235B1 (ko) * 1998-12-07 2009-02-24 엘란 파마 인터내셔널 리미티드 휘발성 액상 약물 전달을 위한 경피성 패취
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US7063859B1 (en) * 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6673363B2 (en) * 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6719997B2 (en) * 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
ES2275670T3 (es) * 2000-03-03 2007-06-16 EISAI R&D MANAGEMENT CO., LTD. Metodos novedosos utilizando inhibidores de colinesterasa.
DE10060852A1 (de) * 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
US6589514B2 (en) * 2001-04-17 2003-07-08 Morinda, Inc. Cosmetic intensive repair serum with morinda citrifolia
US6833478B2 (en) * 2001-07-13 2004-12-21 Sri International N,N-dinitramide salts as solubilizing agents for biologically active agents
US6893655B2 (en) * 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
AU2002340232A1 (en) * 2001-10-17 2003-04-28 Eisai Co., Ltd. Methods for treating substance abuse with cholinesterase inhibitors
US20040258741A1 (en) * 2001-10-17 2004-12-23 Takaaki Terahara Percutaneous absorption preparations
US6787682B2 (en) * 2001-11-05 2004-09-07 Hollister Incorporated Absorbent foam wound dressing
JP2004024724A (ja) * 2002-06-28 2004-01-29 Biopol Co Ltd 多層構造の微細多孔性フォームドレッシング材及びその製造方法
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
US7645462B2 (en) * 2002-08-27 2010-01-12 3T Herbtech, Inc. Acupoint patch
JP4792193B2 (ja) * 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
US7439365B2 (en) * 2003-11-17 2008-10-21 Usv, Ltd. Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil)
US7186842B2 (en) * 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
RS20060332A (sr) * 2003-10-28 2008-04-04 Noven Pharmaceuticals Inc., Kompozicije i postupci za kontrolisanje gubitka i oslobađanja leka u transdermalnim sistemima oslobađanja leka
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
BRPI0621655A2 (pt) * 2006-05-08 2011-12-20 Teikoku Seiyaku Kk preparação para a absorção percutánea de uma droga antidemência básica
JP5097359B2 (ja) * 2006-05-09 2012-12-12 久光製薬株式会社 ドネペジル経皮吸収型製剤
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
US20080131490A1 (en) * 2006-12-01 2008-06-05 Akinori Hanatani Stabilized donepezil-containing patch preparation
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
WO2013078608A1 (en) * 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same

Also Published As

Publication number Publication date
CN102164601A (zh) 2011-08-24
TW201029653A (en) 2010-08-16
CA2733265A1 (en) 2010-04-08
EP2328582A1 (en) 2011-06-08
JP2012504163A (ja) 2012-02-16
AR073696A1 (es) 2010-11-24
EP2328582A4 (en) 2012-02-22
MX2011002260A (es) 2011-04-07
WO2010039381A1 (en) 2010-04-08
IL210970A0 (en) 2011-04-28
US20100080842A1 (en) 2010-04-01
AU2009300184A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
BRPI0917862A2 (pt) composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas
BRPI0920284A2 (pt) composição e método
BRPI0912703A2 (pt) composições imuno-moduladoras e métodos para uso dessas
BRPI0909780A2 (pt) Composições e métodos para liberação de fármaco
BRPI0912046A2 (pt) composições de hibridização e métodos
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
BRPI0908087A2 (pt) Composições e métodos para implante de tecido adipose e produtos de tecido adiposo
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BRPI0922084A2 (pt) Composições e métodos compreendendo variantes de serina protease
BRPI0911228A2 (pt) compostos e composições como inibidores de proteínas quinase
BRPI0914652A2 (pt) compostos e composições como inibidores de quinase
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
SMT201300040B (it) Analoghi piridonici e piridazonici come modulatoridi gpr119
BRPI0914789A2 (pt) efeitos sinérgicos
EP2381760A4 (en) CORN PROTEIN COMPOSITION
BRPI0912026A2 (pt) formulação homeopática
FR2933868B1 (fr) Compositions cosmetiques
EP2356462A4 (en) ANTI-CXCR1 COMPOSITIONS AND METHOD
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI0917231A2 (pt) composição
BRPI0915460A2 (pt) métodos e composições para a liberação intensificada de macromoléculas
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
EP2281635A4 (en) CUTTER
IL210097B (en) Compounds and methods for the treatment of influenza

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]